AccessPak for HIV PEP Expanded with Viracept and Faslodex

• Generic Name: emtricitabine / nelfinavir / tenofovir
• Dosage Forms: n.a.
• Other Brand Names: AccessPak for HIV PEP Expanded with Viracept

AccessPak for HIV PEP Expanded with Viracept are antiviral drugs that prevent human immunodeficiency virus (HIV) from multiplying in your body.

AccessPak for HIV PEP Expanded with Viracept is a combination medicine used to treat HIV, the virus that can cause acquired immunodeficiency syndrome (AIDS). AccessPak for HIV PEP Expanded with Viracept is not a cure for HIV or AIDS.

This medicine may also be used together with safer-sex practices to reduce the risk of becoming infected with HIV. You must be HIV-negative and an adult to use the medicine for this purpose. AccessPak for HIV PEP Expanded with Viracept may not provide protection from disease in every person.

AccessPak for HIV PEP Expanded with Viracept may also be used for purposes not listed in this medication guide.

• Generic Name: fulvestrant
• Dosage Forms: injection
• Other Brand Names: Faslodex

Faslodex (fulvestrant) is an anti-estrogen medication. It works by blocking the actions of estrogen in the body. Certain types of breast cancer use estrogen to grow and multiply in the body.

Faslodex is used in postmenopausal women with hormone-related breast cancer that is advanced or has spread to other parts of the body (metastatic).

Faslodex is used alone or in combination with another medicine called ribociclib (Kisqali) to treat HR-positive, HER2-negative breast cancer in:

• women with no prior treatment; or

• women whose cancer has progressed after treatment with anti-estrogen medication.

Faslodex is used in combination with palbociclib (Ibrance) or abemaciclib (Verzenio) when the cancer has progressed after treatment with anti-estrogen medication.